September 29, 2012 | The Lancet
Sabin Executive Vice President, Dr. Ciro de Quadros recently co-authored the following correspondence, which appeared in the September 29 edition of the Lancet.
Reducing the global burden of congenital rubella syndrome
Rubella, also known as German Measles, is an often mild disease whose symptoms can range from a fever and rash to signs too mild to detect. When contracted by a pregnant woman in her first 20 weeks, however, rubella can lead to Congenital Rubella Syndrome (CRS) in the fetus, and the effects can be devastating. The disease can cause severe growth and mental retardation, deafness and other developmental problems when the fetus becomes infected. Though the burden of CRS is not well documented, the WHO estimates that in developing countries alone 100,000 cases of CRS occur each year.
Progress Toward Rubella Elimination and CRS prevention in Europe was held 8-10 February, 2012 in Rome, Italy. Over 150 people from 47 countries came together to review the latest developments in the fight against rubella and CRS in Europe. A special session on measles was also convened to review the numerous overlaps in these two areas. Proceedings are now available for download above.
February 8, 2012 | Press Release